- £1.49bn
- £1.62bn
- £7.58bn
- 94
- 67
- 27
- 70
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 6,071 | 5,930 | 5,648 | 6,589 | 7,583 |
Cost of Revenue | |||||
Gross Profit | 1,130 | 996 | 918 | 1,189 | 1,295 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 5,837 | 5,834 | 5,553 | 6,379 | 7,386 |
Operating Profit | 234 | 95.1 | 95.1 | 210 | 197 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 231 | 86.3 | 88.1 | 204 | 192 |
Provision for Income Taxes | |||||
Net Income After Taxes | 162 | 47.5 | 61.5 | 154 | 138 |
Net Income Before Extraordinary Items | |||||
Net Income | 162 | 47.5 | 61.5 | 154 | 138 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 162 | 47.5 | 61.5 | 154 | 138 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.122 | 0.057 | 0.034 | 0.093 | 0.085 |
Dividends per Share | |||||
Special Dividends per Share |